Current techniques in wound healing modulation in glaucoma surgery
- PMID: 10163318
- DOI: 10.1097/00055735-199604000-00005
Current techniques in wound healing modulation in glaucoma surgery
Abstract
The wound healing response is the single most important determinant of the final intraocular pressure after glaucoma surgery. The use of antiscarring agents, particularly the antimetabolites 5-fluorouracil and mitomycin C, have revolutionized glaucoma surgery over the past decade. This subject has become more important with the realization that simply lowering the intraocular pressure to below 21 mm Hg is inadequate, and that optimal lowering of the intraocular pressure should be achieved in all patients undergoing surgery for glaucoma. However, the antimetabolites still have many potential problems and side effects, some of which are potentially sightthreatening. This review concentrates on the recent publications in this field that have determined the current "state of the art," with a view toward optimizing results and minimizing side effects for our patients with glaucoma in this exciting and challenging area of progress.
Similar articles
-
[Wound healing modulation in glaucoma surgery].J Fr Ophtalmol. 2007 Jun;30(6):631-46. doi: 10.1016/s0181-5512(07)89673-2. J Fr Ophtalmol. 2007. PMID: 17646754 Review. French.
-
Wound Healing and Glaucoma Surgery: Modulating the Scarring Process with Conventional Antimetabolites and New Molecules.Dev Ophthalmol. 2017;59:80-89. doi: 10.1159/000458488. Epub 2017 Apr 25. Dev Ophthalmol. 2017. PMID: 28442689 Review.
-
[Mitomycin C in glaucoma surgery].Bull Soc Belge Ophtalmol. 1993;247(1):79-86. Bull Soc Belge Ophtalmol. 1993. PMID: 8205344 Review. French.
-
Antifibrotic agents in glaucoma filtering surgery.Int Ophthalmol Clin. 1993 Fall;33(4):165-82. doi: 10.1097/00004397-199303340-00014. Int Ophthalmol Clin. 1993. PMID: 8258494 Review. No abstract available.
-
GGRGDSPCA peptide: a new antiscarring agent on glaucoma filtration surgery.Ophthalmic Surg Lasers. 2001 Mar-Apr;32(2):134-9. Ophthalmic Surg Lasers. 2001. PMID: 11300635
Cited by
-
FGF-2 enhances fibrogenetic changes in TGF-β2 treated human conjunctival fibroblasts.Sci Rep. 2022 Sep 26;12(1):16006. doi: 10.1038/s41598-022-20036-7. Sci Rep. 2022. PMID: 36163231 Free PMC article.
-
Trabeculectomy with subconjunctival collagen implant in Indian eyes: Long-term results.Indian J Ophthalmol. 2018 Oct;66(10):1429-1434. doi: 10.4103/ijo.IJO_462_18. Indian J Ophthalmol. 2018. PMID: 30249827 Free PMC article.
-
Medium to long-term intraocular pressure control following small flap trabeculectomy (microtrabeculectomy) in relatively low risk eyes.Br J Ophthalmol. 1998 Dec;82(12):1383-6. doi: 10.1136/bjo.82.12.1383. Br J Ophthalmol. 1998. PMID: 9930268 Free PMC article.
-
Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners.Int J Mol Sci. 2021 Jul 8;22(14):7335. doi: 10.3390/ijms22147335. Int J Mol Sci. 2021. PMID: 34298955 Free PMC article.
-
TGF-β-induced activation of conjunctival fibroblasts is modulated by FGF-2 and substratum stiffness.PLoS One. 2020 Nov 18;15(11):e0242626. doi: 10.1371/journal.pone.0242626. eCollection 2020. PLoS One. 2020. PMID: 33206726 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous